A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)
Public ClinicalTrials.gov record NCT02004522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (DUO)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3 clinical trial to examine the efficacy of duvelisib monotherapy versus ofatumumab monotherapy in subjects with relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
Study identification
- NCT ID
- NCT02004522
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 319 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2013 (Type not available)
- Primary completion
- May 19, 2017 (Actual)
- Completion
- Jun 2021 (Actual)
- Last update posted
- Sep 21, 2023
2013 – 2021
United States locations
- U.S. sites
- 37
- U.S. states
- 11
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | La Jolla | California | 92093-0698 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Altamonte Springs | Florida | 32701 | — |
| Not listed | Bonita Springs | Florida | 34135-4529 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Cape Coral | Florida | 33990 | — |
| Not listed | Clearwater | Florida | 33761 | — |
| Not listed | Englewood | Florida | 34223 | — |
| Not listed | Fort Myers | Florida | 33916 | — |
| Not listed | Gainesville | Florida | 32605 | — |
| Not listed | Hudson | Florida | 34667 | — |
| Not listed | Inverness | Florida | 34453 | — |
| Not listed | Largo | Florida | 33777 | — |
| Not listed | Naples | Florida | 34119 | — |
| Not listed | New Port Richey | Florida | 34655 | — |
| Not listed | Orange City | Florida | 32763 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Port Charlotte | Florida | 33980 | — |
| Not listed | Sarasota | Florida | 34236 | — |
| Not listed | Spring Hill | Florida | 34608 | — |
| Not listed | St. Petersburg | Florida | 33705 | — |
| Not listed | Tampa | Florida | 33607 | — |
| Not listed | Tavares | Florida | 32778 | — |
| Not listed | Venice | Florida | 34292 | — |
| Not listed | Crestview Hills | Kentucky | 41017 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | St Louis | Missouri | 63130 | — |
| Not listed | Hackensack | New Jersey | 07601 | — |
| Not listed | New Brunswick | New Jersey | 08903 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | New York | New York | 10065 | — |
| Not listed | Cincinnati | Ohio | 45236 | — |
| Not listed | Fairfield | Ohio | 45014 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02004522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2023 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02004522 live on ClinicalTrials.gov.